Swaminathan, Sathyamangalam ; Batra, Gaurav ; Khanna, Navin (2010) Dengue vaccines: state of the art Expert Opinion on Therapeutic Patents, 20 (6). pp. 819-835. ISSN 1354-3776
Full text not available from this repository.
Official URL: http://www.tandfonline.com/doi/abs/10.1517/1354377...
Related URL: http://dx.doi.org/10.1517/13543771003767476
Abstract
Importance of the Field: Dengue is a significant public health problem transcending geographical boundaries to place nearly 50% of the global population at risk. A vaccine to prevent dengue is an unmet need that should be addressed urgently. Areas Covered in the Review: A brief introduction to dengue and a detailed review of the classical and modern approaches being undertaken currently to develop dengue vaccines described in recent patent literature, highlighting the inherent hurdles and challenges. What the reader will gain: An understanding of the approaches being deployed to develop multiple viral and non-viral vaccine candidates and an appreciation of the complexity of developing dengue vaccines. Take Home Message: Live viral vaccines, which have advanced to clinical trials, have revealed new challenges, emphasizing the need to pursue non-viral alternatives simultaneously.
Item Type: | Article |
---|---|
Source: | Copyright of this article belongs to Taylor & Francis Group. |
Keywords: | Chimeric Vaccines; Dengue Vaccines; Envelope Domain III; Gene Shuffling; Live Attenuated Vaccines; Replivax; Viral Interference |
ID Code: | 109067 |
Deposited On: | 09 Mar 2018 12:12 |
Last Modified: | 09 Mar 2018 12:12 |
Repository Staff Only: item control page